中國抗體SM17新藥研究申請再獲國家藥監局批准
Retrieved on:
星期二, 九月 12, 2023
Current approved therapies for AD, including biologics, can significantly improve eczema area and severity index and patient's quality of life.
IL-25 is a critical cytokine classified as "alarmin", which has shown to be implicated in the pathogenesis of multiple airway viral responses and allergic diseases, such as asthma.
The present IND submission, once granted, will enable the Company to conduct comprehensive clinical development program in China which leads to indication for treatment of asthma.
The present IND submission, once granted, will enable the Company to conduct comprehensive clinical development program in China which leads to indication for treatment of asthma.